Pomalidomide plus Bortezomib plus Low-Dose Dexamethasone Vs Bortezomib plus Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma: A Subgroup Analysis of the Phase 3 Optimismm Trial

Authors :: Dimopoulos, Meletios A. Weisel, Katja Moreau, Philippe and Anderson, Larry White, Darrell J. San-Miguel, Jesus F. and Sonneveld, Pieter Engelhardt, Monika Jenner, Matthew W. and Corso, Alessandro Duerig, Jan Pavic, Michel Salomo, Morten and Yu, Xin Tuong Vi Nguyen Bensmaine, Amine Peluso, Teresa and Zaki, Mohamed Richardson, Paul
Publication Year :: 2018

Tools